Panacea Biotec posts consolidated loss of Rs. 57.35 Cr in Q1FY22
Chemical

Panacea Biotec posts consolidated loss of Rs. 57.35 Cr in Q1FY22

It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.

  • By ICN Bureau | July 26, 2021

Panacea Biotec has reported total income of Rs.135.68 crores during the period ended June 30, 2021 as compared to Rs.173.17 crores during the period ended March 31, 2021. The company has reported total income of Rs.133.95 crores during the period ended June 30, 2020.

The company has posted loss of Rs.(57.35) crores for the period ended June 30, 2021 as against net lossof Rs. (54.14) crores for the period ended March 31, 2021. It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.

Register Now to Attend Chem Connect 2025 on August 21th 2025, Novotel Mumbai International Airport

Upcoming Conferences

Chem Connect 2025

August 21, 2025

Other Related stories

Startups

Petrochemical

Energy

Digitization